High-performance liquid chromatographic and pharmacokinetic analyses of an intravenous submicron emulsion of perillyl alcohol in rats

    loading  Checking for direct PDF access through Ovid


Perillyl alcohol (POH) is currently in phase II clinical trials both as a chemopreventative and chemotherapeutic agent. The present report describes a simple, rapid and sensitive HPLC-UV method to quantify POH in rat plasma. After protein precipitation with acetonitrile, POH was separated using an Agilent Zorbax XDB C18 column (150 mm × 4.6 mm, 5 μm) with a mobile phase consisting of acetonitrile–water (40:60, v/v) at a flow rate of 1.0 ml min−1, and detected at 210 nm. The method has been used successfully to determine trace levels of POH in plasma down to 0.015 μg ml−1. The pharmacokinetics of POH after intravenous administrations in three formulations, i.e. POH solution (POH-SOL), negatively charged submicron emulsions (POH-SE) and positively charged submicron emulsions (POH-CSSE) were investigated. AUC0–∞, MRT, t1/2α and t1/2β of POH-SE and POH-CSSE were significantly higher, while their total body clearance was lower than those of POH-SOL. In addition, AUC0–∞, MRT and t1/2β of POH-CSSE were significantly higher than those of POH-SE. The results indicate that the submicron emulsion formulation significantly increases POH blood concentrations and retention within the systemic circulation.

Related Topics

    loading  Loading Related Articles